Immune mediators in inflammatory heart disease: insights from a mouse model
W. Harry Feinstone Department of Molecular Microbiology and Immunology and Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland, U.S.A.
1 Correspondence: Noel R. Rose, The Johns Hopkins University, Department of Pathology, Rutland Avenue, Ross Building, Room 659, Baltimore, MD 21205, U.S.A.
Abstract
Cardiac myosin-induced murine myocarditis provides a useful model for assessing the role of immune mediators in the development of inflammatory heart disease. Myocarditis is characterized by leucocyte infiltration, fibrosis, and cardiomyocyte death, which collectively lead to deterioration of both systolic and diastolic function as assessed by pressure-volume relations. In severe cases, disease progresses to dilated cardiomyopathy and heart failure. Key factors that promote disease include complement, tumour necrosis factor-alpha, interleukin-4, and interleukin-12. Factors found to supress myocarditis include interferon-gamma, interleukin-10, and cyotoxic T lymphocyte antigen-4. Final disease outcome is determined by the interplay of these immune mediators.
Key Words: Autoimmunity cardiomyopathy cytokines knockout mice myocarditis pressure-volume relations
References
- Feldman AM, McNamara D. Myocarditis. N Engl J Med. 2000;343:13881398
[Free Full Text] - Higuchi MD, Ries MM, Aiello VD, et al. Association of an increase in CD8+T cells with the presence of Trypanosoma cruzi antigens in chronic, human, chagasic myocarditis. Am J Trop Med Hyg. 1997;56:485489
- Fairweather D, Kaya Z, Shellam GR, Lawson CM, Rose NR. From infection to autoimmunity. J Autoimmun. 2001;16:175186[CrossRef][ISI][Medline]
- Rose NR, Hill SL. The pathogenesis of postinfectious myocarditis. Clin Immunol Immunopathol. 1996;80:S92S99[CrossRef][ISI][Medline]
- Cooper LT Jr., Berry GJ, Shabetai R. Idiopathic giant-cell myocarditis: natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. N Engl J Med. 1997;336:18601866
[Abstract/Free Full Text] - Litovsky SH, Burke AP, Virmani R. Giant cell myocarditis: an entity distinct from sarcoidisis characterized by multiphasic myocyte destruction by cytotoxic T cells and histicytic giant cells. Mod Pathol. 1996;9:11261134[ISI][Medline]
- Humbert P, Faivre R, Fellman D, Bassand JP, Dupond JL. Giant cell myocarditis: an autoimmune disease? Am Heart J. 1988;115:485487[CrossRef][ISI][Medline]
- McNally AK, Anderson JM. Interleukin-4 induces foreign body giant cells from human monocyte/macrophages. Differential lymphokine regulation of macrophage fusion leads to morphological variants of multinucleated giant cells. Am J Pathol. 1995;147:14871499[Abstract]
- Kodama M, Matsumoto Y, Fujiwara M, et al. Characteristics of giant cells and factors related to the formation of giant cells in myocarditis. Circ Res. 1991;69:10421050
[Abstract/Free Full Text] - Burke JS, Medline NM, Katz A. Giant cell myocarditis and myositis. Associated with thymoma and myasthenia gravis. Arch Pathol. 1969;88:359366[ISI][Medline]
- Kloin JE. Pernicious anemia and giant cell myocarditis. New association. Am J Med. 1985;78:355360[CrossRef][ISI][Medline]
- McKeon J, Haagsma B, Bett JH, Boyle CM. Fatal giant cell myocarditis after colectomy for ulcerative colitis. Am Heart J. 1986;111:12081209[CrossRef][ISI][Medline]
- Hales SA, Theaker JM, Gatter KC. Giant cell myocarditis associated with lymphoma: an immunocytochemical study. J Clin Pathol. 1987;40:13101313
[Abstract/Free Full Text] - Neu N, Rose NR, Beisel KW, Herskowitz A, Gurri-Glass G, Craig SW. Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol. 1987;139:36303636[Abstract]
- Caforio AL, Goldman JH, Haven AJ, Baig KM, McKenna WJ. Evidence for autoimmunity to myosin and other heart-specific autoantigens in patients with dilated cardiomyopathy and their relatives. Int J Cardiol. 1996;54:157163[CrossRef][ISI][Medline]
- Lauer B, Schannwell M, Kuhl U, Strauer BE, Schultheiss HP. Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. J Am Coll Cardiol. 2000;35:1118
[Abstract/Free Full Text] - Wang Y, Afanasyeva M, Hill SL, Rose NR. Characterization of murine autoimmune myocarditis induced by self and foreign cardiac myosin. Autoimmunity. 1999;31:151162[ISI][Medline]
- Kodama M, Matsumoto Y, Fujiwara M, Masani F, Izumi T, Shibata A. A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin Immunol Immunopathol. 1990;57:250262[CrossRef][ISI][Medline]
- Georgakopoulos D, Mitzner WA, Chen CH, et al. In vivo murine left ventricular pressure-volume relations by miniaturized conductance micromanometry. Am J Physiol. 1998;274:H1416H1422
- Kaya Z, Afanasyeva M, Wang Y, et al. Contribution of the innate immune system to autoimmune myocarditis: a role for complement. Nat Immunol. 2001;2:739745[CrossRef][ISI][Medline]
- Carroll MC. The role of complement and complement receptors in induction and regulation of immunity. Annu Rev Immunol. 1998;16:545568[CrossRef][ISI][Medline]
- Yokoyama T, Vaca L, Rossen RD, Durante W, Hazarika P, Mann DL. Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest. 1993;92:23032312
- Kubota T, McTiernan CF, Frye CS, et al. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res. 1997;81:627635
[Abstract/Free Full Text] - Bryant D, Becker L, Richardson J, et al. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation. 1998;97:13751381
[Abstract/Free Full Text] - Smith SC, Allen PM. Neutralization of endogeneous tumor necrosis factor ameliorates the severity of myosin-induced myocarditis. Circ Res. 1992;70:856863
[Abstract/Free Full Text] - Bachmaier K, Pummerer C, Kozieradzki I, et al. Low-molecular-weight tumor necrosis factor receptor p55 controls induction of autoimmune heart disease. Circulation. 1997;95:655661
[Abstract/Free Full Text] - Afanasyeva M, Wang Y, Kaya Z, et al. Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype. Am J Pathol. 2001;159:193203
[Abstract/Free Full Text] - Afanasyeva M, Wang Y, Kaya Z, et al. Interleukin-12 receptor/STAT4 signaling is required for the development of autoimmune myocarditis in mice by an interferon-gamma-ibdependent pathway. Circulation. 2001;104:31453151
[Abstract/Free Full Text] - Okura Y, Takeda K, Honda S, et al. Recombinant murine interleukin-12 facilitates induction of cardiac myosin-specific type 1 helper T cells in rats. Circ Res. 1998;82:10351042
[Abstract/Free Full Text] - Eriksson U, Kurrer MO, Sebald W, Brombacher F, Kopf M. Dual role of the IL-12/IFN-gamma axis in the development of autoimmune myocarditis: induction by IL-12 and protection by IFN-gamma. J Immunol. 2001;167:54645469
[Abstract/Free Full Text] - Eriksson U, Kurrer MO, Bingisser R, et al. Lethal autoimmune myocarditis in interferon-gamma receptor-deficient mice: enhanced disease severity by impaired inducible nitric oxide synthase induction. Circulation. 2001;103:1821
[Abstract/Free Full Text] - Afanasyeva M. The role of T helper 1 and T helper 2 cytokines in murine experimental autoimmune myocarditis. Ph.D. Thesis. : The Johns Hopkins University; 2002.
- Moore KW, de Waal MR, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001;19:683765[CrossRef][ISI][Medline]
- Kaya Z, Dohmen KM, Wang Y, et al. Cutting edge: a critical role for IL-10 in induction of nasal tolerance in experimental autoimmune myocarditis. J Immunol. 2002;168:15521556
[Abstract/Free Full Text] - Wang Y, Afanasyeva M, Hill SL, Kaya Z, Rose NR. Nasal administration of cardiac myosin suppresses autoimmune myocarditis in mice. J Am Coll Cardiol. 2000;36:19921999
[Abstract/Free Full Text] - Salomon B, Bluestone JA. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol. 2001;19:225252[CrossRef][ISI][Medline]
- Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 1995;3(5):541547[CrossRef][ISI][Medline]
- Penninger JM, Neu N, Bachmaier K. A genetic map of autoimmune heart disease. Immunologist. 1996;4:131141
- Molina H, Holers VM, Li B, et al. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc Natl Acad Sci USA. 1996. p. 33573361
- Pfeffer K, Matsuyama T, Kundig TM, et al. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell. 1993;73:457467[CrossRef][ISI][Medline]
- Wu C, Ferrante J, Gately MK, Magram J. Characterization of IL-12 receptor betal chain (IL-12Rbeta1)-deficient mice: IL-12Rbeta1 is an essential component of the functional mouse IL-12 receptor. J Immunol. 1997;159:16581665[Abstract]
- Magram J, Connaughton SE, Warrier RR, et al. IL-12 deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity. 1996;4:471481[CrossRef][ISI][Medline]
- Kaplan MH, Sun Y-L, Hoey T, Grusby MJ. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature. 1996;382:174177[CrossRef][Medline]
- Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science. 1993;259:17391742
[Abstract/Free Full Text] - Huang S, Hendriks W, Althage A, et al. Immune response in mice that lack the interferon-gamma receptor. Science. 1993;259:17421745
[Abstract/Free Full Text]
This article has been cited by other articles:
![]() |
M. Afanasyeva, D. Georgakopoulos, D. F. Belardi, A. C. Ramsundar, J. G. Barin, D. A. Kass, and N. R. Rose Quantitative Analysis of Myocardial Inflammation by Flow Cytometry in Murine Autoimmune Myocarditis: Correlation with Cardiac Function Am. J. Pathol., March 1, 2004; 164(3): 807 - 815. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
